Latest news for Krones (OTC:KRNTY) Stock

Krones AG offers machinery and systems for filling, packaging, and producing beverages. Part of its product portfolio is information technology and planning associated with logistics and production lines. In addition to packaging, the company has cellar systems to treat and store sensitive beverages. The company's reportable segments are: Filling and Packaging Technology, Process Technology, and Intralogistics. The majority of the company's revenue is generated from its Fillings and Packaging segment which offers machines and lines for filling, labelling, packaging and conveying products. Geographically, the company generates a majority of its revenue from Germany and the rest from China, Middle East and Africa, America and other regions.

Krones AG

Krones: Trading At A 10% Forward FCF Yield For 2025

Krones AG 2023 Q4 - Results - Earnings Call Presentation

Krones AG (KRNNF) Q4 2023 Earnings Call Transcript

Krones AG (KRNNF) Q1 2024 Earnings Call Transcript

Krones AG goes ex dividend tomorrow

Krones AG (KRNNF) Q2 2024 Earnings Call Transcript

Krones: Ambitious EBITDA Growth Plans By 2028

Krones AG 2024 Q3 - Results - Earnings Call Presentation

Krones AG (KRNNF) Q3 2024 Earnings Call Transcript

KRNNF

KRNTY

Krones

&nbsp;

<h2>Upgrades</h2>

<ul>
	<li>Morgan Stanley upgraded the previous rating for Wayfair Inc (NYSE:<a class="ticker" href="/stock/W#NYSE">W</a>) from Underweight to Equal-Weight. Wayfair earned $1.24 in the fourth quarter, compared to $2.80 in the year-ago quarter. The current stock performance of Wayfair shows a 52-week-high of $369.00 and a 52-week-low of $21.70. Moreover, at the end of the last trading period, the closing price was at $258.34.</li>
	<li>Credit Suisse upgraded the previous rating for Elanco Animal Health Inc (NYSE:<a class="ticker" href="/stock/ELAN#NYSE">ELAN</a>) from Neutral to Outperform. For the fourth quarter, Elanco Animal Health had an EPS of $0.12, compared to year-ago quarter EPS of $0.23. The stock has a 52-week-high of $34.09 and a 52-week-low of $15.17. At the end of the last trading period, Elanco Animal Health closed at $31.68.</li>
	<li>According to Pareto, the prior rating for Dorian LPG Ltd (NYSE:<a class="ticker" href="/stock/LPG#NYSE">LPG</a>) was changed from Sell to Hold. In the third quarter, Dorian LPG showed an EPS of $0.70, compared to $0.63 from the year-ago quarter. The stock has a 52-week-high of $14.90 and a 52-week-low of $6.08. At the end of the last trading period, Dorian LPG closed at $13.09.</li>
	<li>Compass Point upgraded the previous rating for Kinsale Capital Group Inc (NASDAQ:<a class="ticker" href="/stock/KNSL#NASDAQ">KNSL</a>) from Neutral to Buy. Kinsale Capital Group earned $1.14 in the fourth quarter, compared to $0.63 in the year-ago quarter. The stock has a 52-week-high of $252.69 and a 52-week-low of $80.93. At the end of the last trading period, Kinsale Capital Group closed at $168.53.</li>
	<li>For Sunnova Energy International Inc (NYSE:<a class="ticker" href="/stock/NOVA#NYSE">NOVA</a>), Credit Suisse upgraded the previous rating of Neutral to Outperform. For the fourth quarter, Sunnova Energy Intl had an EPS of $0.00, compared to year-ago quarter EPS of $0.21. At the moment, the stock has a 52-week-high of $57.70 and a 52-week-low of $6.12. Sunnova Energy Intl closed at $41.83 at the end of the last trading period.</li>
	<li>For HP Inc (NYSE:<a class="ticker" href="/stock/HPQ#NYSE">HPQ</a>), JP Morgan upgraded the previous rating of Neutral to Overweight. In the first quarter, HP showed an EPS of $0.92, compared to $0.65 from the year-ago quarter. The current stock performance of HP shows a 52-week-high of $30.00 and a 52-week-low of $12.54. Moreover, at the end of the last trading period, the closing price was at $28.24.</li>
	<li>According to Morgan Stanley, the prior rating for L Brands Inc (NYSE:<a class="ticker" href="/stock/LB#NYSE">LB</a>) was changed from Equal-Weight to Overweight. For the fourth quarter, L Brands had an EPS of $3.03, compared to year-ago quarter EPS of $1.88. At the moment, the stock has a 52-week-high of $57.19 and a 52-week-low of $8.00. L Brands closed at $52.14 at the end of the last trading period.</li>
	<li>Morgan Stanley upgraded the previous rating for Carvana Co (NYSE:<a class="ticker" href="/stock/CVNA#NYSE">CVNA</a>) from Equal-Weight to Overweight. For the fourth quarter, Carvana had an EPS of $0.40, compared to year-ago quarter EPS of $0.79. The stock has a 52-week-high of $314.56 and a 52-week-low of $22.16. At the end of the last trading period, Carvana closed at $264.00.</li>
	<li>Atlantic Equities upgraded the previous rating for American International Group Inc (NYSE:<a class="ticker" href="/stock/AIG#NYSE">AIG</a>) from Neutral to Overweight. In the fourth quarter, American Intl Gr showed an EPS of $0.94, compared to $1.03 from the year-ago quarter. The stock has a 52-week-high of $46.34 and a 52-week-low of $16.07. At the end of the last trading period, American Intl Gr closed at $43.98.</li>
	<li>RBC Capital upgraded the previous rating for Owl Rock Capital Corp (NYSE:<a class="ticker" href="/stock/ORCC#NYSE">ORCC</a>) from Sector Perform to Outperform. Owl Rock Capital earned $0.29 in the fourth quarter, compared to $0.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $15.55 and a 52-week-low of $8.09. Owl Rock Capital closed at $13.77 at the end of the last trading period.</li>
	<li>For Canfor Pulp Products Inc (OTC:<a class="ticker" href="/stock/CFPUF#OTC">CFPUF</a>), RBC Capital upgraded the previous rating of Sector Perform to Outperform. At the moment, the stock has a 52-week-high of $6.05 and a 52-week-low of $2.87. Canfor Pulp Products closed at $7.32 at the end of the last trading period.</li>
	<li>For LivePerson Inc (NASDAQ:<a class="ticker" href="/stock/LPSN#NASDAQ">LPSN</a>), JP Morgan upgraded the previous rating of Neutral to Overweight. In the fourth quarter, LivePerson showed an EPS of $0.20, compared to $0.43 from the year-ago quarter. The current stock performance of LivePerson shows a 52-week-high of $72.23 and a 52-week-low of $14.08. Moreover, at the end of the last trading period, the closing price was at $58.17.</li>
</ul>

<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>

&nbsp;

<h2>Downgrades</h2>

<ul>
	<li>According to Morgan Stanley, the prior rating for Pandion Therapeutics Inc (NASDAQ:<a class="ticker" href="/stock/PAND#NASDAQ">PAND</a>) was changed from Overweight to Equal-Weight. Interestingly, in the third quarter, Pandion Therapeutics&#39;s EPS was $0.51. At the moment, the stock has a 52-week-high of $60.71 and a 52-week-low of $10.28. Pandion Therapeutics closed at $59.81 at the end of the last trading period.</li>
	<li>Wedbush downgraded the previous rating for Fate Therapeutics Inc (NASDAQ:<a class="ticker" href="/stock/FATE#NASDAQ">FATE</a>) from Outperform to Neutral. In the fourth quarter, Fate Therapeutics showed an EPS of $0.61, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of $121.16 and a 52-week-low of $16.75. Fate Therapeutics closed at $86.27 at the end of the last trading period.</li>
	<li>For Waterstone Financial Inc (NASDAQ:<a class="ticker" href="/stock/WSBF#NASDAQ">WSBF</a>), Piper Sandler downgraded the previous rating of Overweight to Neutral. In the fourth quarter, Waterstone Financial showed an EPS of $1.17, compared to $0.34 from the year-ago quarter. The current stock performance of Waterstone Financial shows a 52-week-high of $20.95 and a 52-week-low of $12.10. Moreover, at the end of the last trading period, the closing price was at $20.21.</li>
	<li>For Sage Therapeutics Inc (NASDAQ:<a class="ticker" href="/stock/SAGE#NASDAQ">SAGE</a>), Mizuho downgraded the previous rating of Buy to Neutral. For the fourth quarter, Sage Therapeutics had an EPS of $18.19, compared to year-ago quarter EPS of $3.25. The stock has a 52-week-high of $98.39 and a 52-week-low of $25.01. At the end of the last trading period, Sage Therapeutics closed at $83.45.</li>
	<li>According to JP Morgan, the prior rating for SLR Investment Corp (NASDAQ:<a class="ticker" href="/stock/SLRC#NASDAQ">SLRC</a>) was changed from Overweight to Neutral. SLR Investment earned $0.35 in the fourth quarter, compared to $0.41 in the year-ago quarter. The stock has a 52-week-high of $20.04 and a 52-week-low of $7.42. At the end of the last trading period, SLR Investment closed at $19.14.</li>
	<li>Stifel downgraded the previous rating for World Fuel Services Corp (NYSE:<a class="ticker" href="/stock/INT#NYSE">INT</a>) from Buy to Hold. In the fourth quarter, World Fuel Services showed an EPS of $0.02, compared to $0.87 from the year-ago quarter. The current stock performance of World Fuel Services shows a 52-week-high of $36.76 and a 52-week-low of $18.36. Moreover, at the end of the last trading period, the closing price was at $35.02.</li>
	<li>For WNS (Holdings) Ltd (NYSE:<a class="ticker" href="/stock/WNS#NYSE">WNS</a>), Baird downgraded the previous rating of Outperform to Neutral. In the third quarter, WNS (Hldgs) showed an EPS of $0.79, compared to $0.80 from the year-ago quarter. At the moment, the stock has a 52-week-high of $78.07 and a 52-week-low of $34.26. WNS (Hldgs) closed at $76.90 at the end of the last trading period.</li>
	<li>For Fly Leasing Ltd (NYSE:<a class="ticker" href="/stock/FLY#NYSE">FLY</a>), Deutsche Bank downgraded the previous rating of Buy to Hold. Fly Leasing earned $0.01 in the fourth quarter, compared to $2.49 in the year-ago quarter. At the moment, the stock has a 52-week-high of $17.99 and a 52-week-low of $3.41. Fly Leasing closed at $12.59 at the end of the last trading period.</li>
	<li>According to Morgan Stanley, the prior rating for Verra Mobility Corp (NASDAQ:<a class="ticker" href="/stock/VRRM#NASDAQ">VRRM</a>) was changed from Overweight to Equal-Weight. Verra Mobility earned $0.04 in the third quarter, compared to $0.11 in the year-ago quarter. At the moment, the stock has a 52-week-high of $17.07 and a 52-week-low of $5.63. Verra Mobility closed at $14.12 at the end of the last trading period.</li>
	<li>For Agios Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="/stock/AGIO#NASDAQ">AGIO</a>), SVB Leerink downgraded the previous rating of Outperform to Market Perform. In the fourth quarter, Agios Pharmaceuticals showed an EPS of $1.41, compared to $1.60 from the year-ago quarter. The stock has a 52-week-high of $58.93 and a 52-week-low of $27.77. At the end of the last trading period, Agios Pharmaceuticals closed at $50.29.</li>
	<li>For Voyager Therapeutics Inc (NASDAQ:<a class="ticker" href="/stock/VYGR#NASDAQ">VYGR</a>), Baird downgraded the previous rating of Outperform to Neutral. For the fourth quarter, Voyager Therapeutics had an EPS of $0.43, compared to year-ago quarter EPS of $0.34. The current stock performance of Voyager Therapeutics shows a 52-week-high of $14.62 and a 52-week-low of $6.16. Moreover, at the end of the last trading period, the closing price was at $6.23.</li>
	<li>Raymond James downgraded the previous rating for Best Buy Co Inc (NYSE:<a class="ticker" href="/stock/BBY#NYSE">BBY</a>) from Strong Buy to Outperform. Best Buy Co earned $3.48 in the fourth quarter, compared to $2.90 in the year-ago quarter. The stock has a 52-week-high of $124.89 and a 52-week-low of $48.10. At the end of the last trading period, Best Buy Co closed at $102.87.</li>
	<li>For Pandion Therapeutics Inc (NASDAQ:<a class="ticker" href="/stock/PAND#NASDAQ">PAND</a>), SVB Leerink downgraded the previous rating of Outperform to Market Perform. In the third quarter, Pandion Therapeutics earned $0.51. The current stock performance of Pandion Therapeutics shows a 52-week-high of $60.71 and a 52-week-low of $10.28. Moreover, at the end of the last trading period, the closing price was at $59.81.</li>
</ul>

<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>

&nbsp;

<h2>Initiations</h2>

<ul>
	<li>Roth Capital initiated coverage on Amyris Inc (NASDAQ:<a class="ticker" href="/stock/AMRS#NASDAQ">AMRS</a>) with a Buy rating. The price target for Amyris is set to $20.00. For the third quarter, Amyris had an EPS of $0.18, compared to year-ago quarter EPS of $0.45. The current stock performance of Amyris shows a 52-week-high of $18.57 and a 52-week-low of $1.40. Moreover, at the end of the last trading period, the closing price was at $13.82.</li>
	<li>Rosenblatt initiated coverage on Elastic NV (NYSE:<a class="ticker" href="/stock/ESTC#NYSE">ESTC</a>) with a Buy rating. The price target for Elastic is set to $175.00. In the third quarter, Elastic showed an EPS of $0.04, compared to $0.28 from the year-ago quarter. The current stock performance of Elastic shows a 52-week-high of $176.49 and a 52-week-low of $39.01. Moreover, at the end of the last trading period, the closing price was at $131.54.</li>
	<li>With an Outperform rating, Oppenheimer initiated coverage on icad Inc (NASDAQ:<a class="ticker" href="/stock/ICAD#NASDAQ">ICAD</a>). The price target seems to have been set at $27.00 for icad. In the fourth quarter, icad showed an EPS of $0.06, compared to $0.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $18.88 and a 52-week-low of $5.91. icad closed at $17.19 at the end of the last trading period.</li>
	<li>Deutsche Bank initiated coverage on Sika AG (OTC:<a class="ticker" href="/stock/SXYAY#OTC">SXYAY</a>) with a Buy rating. The current stock performance of Sika shows a 52-week-high of $27.26 and a 52-week-low of $13.76. Moreover, at the end of the last trading period, the closing price was at $26.98.</li>
</ul>

<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

Upgrades

Downgrades

Initiation

Intraday Update

Analyst Ratings

AGIO

AMRS

BRLXF

CEQP

CFPUF

CVNA

ELAN

ESTC

FATE

GBERY

GMVHF

HXPLF

ICAD

KGSPY

KNSL

LPSN

NOVA

ORCC

PAND

SAGE

SDVKY

SLRC

SUNS

SXYAY

TCPC

VRRM

VYGR

WSBF

Benzinga's Top Ratings Upgrades, Downgrades For February 26, 2021

HSBC analyst Richard Schramm downgrades Krones (OTC:<a class="ticker" href="/stock/KRNTY#OTC">KRNTY</a>) from Buy to Hold.

News

HSBC Downgrades Krones to Hold

Comments

Krones

News

Latest news for Krones (OTC:KRNTY) Stock

Friday, February 26, 2021

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga